A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated
Clinical trial NCT05183360 · TERMINATED
Trial details
- NCT number
- NCT05183360
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-07
- Primary completion
- 2022-08-12
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.